Malaysia vs Venezuela: Access to anti-retroviral drugs, male (%)
Malaysia
59.0%
in 2024
Venezuela
59.0%
in 2024
Malaysia rank
105th
Venezuela rank
105th
Access to anti-retroviral drugs, male (%) over time
- Malaysia
- Venezuela
How they compare
Malaysia currently reports 59.0% against 59.0% in Venezuela, a difference of 0.0%.
The two have swapped places 2 times across 23 shared years of data; in 2000 it was Venezuela ahead.
Malaysia ranks 105th and Venezuela ranks 105th of 141 countries.
Venezuela has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.2% | 14.6% | 7.4% | Venezuela |
| 2010s | 29.7% | 44.1% | 14.4% | Venezuela |
| 2020s | 55.7% | 62.7% | 7.0% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Malaysia or Venezuela?
- Malaysia, at 59.0% against 59.0% in Venezuela as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Malaysia and Venezuela?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Venezuela?
- 23 years are reported by both, from 2000 to 2024.
- How do Malaysia and Venezuela rank globally for access to anti-retroviral drugs, male?
- Malaysia ranks 105th and Venezuela ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.